Literature DB >> 12678790

Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?

M H Dowsland1, J R Harvey, T W J Lennard, J A Kirby, S Ali.   

Abstract

Breast cancer is an example of a solid tumour which is well treated in the early stages of disease by surgical excision, but once metastatic spread has occurred, medical therapies (chemotherapy and radiotherapy) are highly toxic, expensive and palliative. It is known that certain tumours exhibit specific patterns of metastasis, chemokines may provide a molecular answer to this mystery. Chemokines and their receptors play important roles in the various stages of tumour development and metastasis. Chemokines interact with their specific receptors as well as interacting with the glycosaminoglycan (GAG) component of proteoglycan. We discuss the basic metastatic process and the involvement of chemokines in breast cancer biology. Finally, we summarize potential therapeutic applications of chemokines and chemokine/glycosaminoglycan interactions including chemokine agonists, antagonists, anti-sense therapy, immunotherapy and soluble GAGs, as well as future perspectives in this field.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678790     DOI: 10.2174/0929867033457944

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

Review 1.  Clinical utilization of chemokines to combat cancer: the double-edged sword.

Authors:  Chiara Dell'Agnola; Arya Biragyn
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

Review 2.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

4.  Effect of acupuncture on CXCL8 receptors in rats suffering from embryo implantation failure.

Authors:  Wei-Na Gao; Wei Yang; Ya-Fei Liu; Xiao Tang; Yue Guo; Li-Jun Wang; Ming-Min Zhang; Guang-Ying Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

Review 5.  Immunohistochemical expression of CXCR4 on breast cancer and its clinical significance.

Authors:  Marina Okuyama Kishima; Carlos Eduardo Coral de Oliveira; Bruna Karina Banin-Hirata; Roberta Losi-Guembarovski; Karen Brajão de Oliveira; Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-16       Impact factor: 2.916

Review 6.  Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.

Authors:  Maria E Reyes; Marjorie de La Fuente; Marcela Hermoso; Carmen G Ili; Priscilla Brebi
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

7.  Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo.

Authors:  P Mellor; J R Harvey; K J Murphy; D Pye; G O'Boyle; T W J Lennard; J A Kirby; S Ali
Journal:  Br J Cancer       Date:  2007-08-28       Impact factor: 7.640

8.  RUNX2, GPX3 and PTX3 gene expression profiling in cumulus cells are reflective oocyte/embryo competence and potentially reliable predictors of embryo developmental competence in PCOS patients.

Authors:  Xin Huang; Cuifang Hao; Xiaofang Shen; Yuhua Zhang; Xiaoyan Liu
Journal:  Reprod Biol Endocrinol       Date:  2013-11-26       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.